Looking to the future of medical device supply chains
To ensure high-quality, low-cost care even amid disasters and rid itself of foreign dependencies that could have deadly consequences, the U.S.’s medical device supply chain must transform. Decentralization and localized manufacturing need to be a key part of the regulatory environment and market incentivization, and predictive analytics tools that already exist simply need to be applied and utilized. Our healthcare system’s resilience depends on the steps we take now. By investing in reshoring, digitization of our supply chains, and embracing public-private partnerships, we can ensure that no patient is left waiting for lifesaving care during the next crisis. The time to act is now.
About the author: Marcel Botha is the CEO and founder of 10XBeta.
Ad Statistics
Times Displayed: 1581
Times Visited: 8 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
Back to HCB News
